| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.25 | 6e-12 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.2 | 1e-08 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-08 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.14 | 9e-05 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0002 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.0002 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.0002 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |